+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vaccine Vials Market Research Report by Type (Multi Dose and Single Dose), by Application (Preventive Vaccine and Therapeutic Vaccine), by Material, by Capacity, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5239948
  • Report
  • September 2021
  • Region: United States
  • 60 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Vaccine Vials Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Vaccine Vials Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Vaccine Vials Market was studied across Multi Dose and Single Dose.
  • Based on Application, the Vaccine Vials Market was studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Material, the Vaccine Vials Market was studied across Glass and Polymer.
  • Based on Capacity, the Vaccine Vials Market was studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
  • Based on State, the Vaccine Vials Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the United States Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the United States Vaccine Vials Market?
6. What is the market share of the leading vendors in the United States Vaccine Vials Market?
7. What modes and strategic moves are considered suitable for entering the United States Vaccine Vials Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Application Outlook
3.5. Material Outlook
3.6. Capacity Outlook
3.7. State Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Vaccine Vials Market, by Type
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose

7. Vaccine Vials Market, by Application
7.1. Introduction
7.2. Preventive Vaccine
7.3. Therapeutic Vaccine

8. Vaccine Vials Market, by Material
8.1. Introduction
8.2. Glass
8.3. Polymer

9. Vaccine Vials Market, by Capacity
9.1. Introduction
9.2. 10ml
9.3. 20ml
9.4. 2ml
9.5. 3ml
9.6. 5ml

10. California Vaccine Vials Market
10.1. Introduction

11. Florida Vaccine Vials Market
11.1. Introduction

12. Illinois Vaccine Vials Market
12.1. Introduction

13. New York Vaccine Vials Market
13.1. Introduction

14. Ohio Vaccine Vials Market
14.1. Introduction

15. Pennsylvania Vaccine Vials Market
15.1. Introduction

16. Texas Vaccine Vials Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES VACCINE VIALS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 3. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 (USD MILLION)
FIGURE 5. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 (USD MILLION)
FIGURE 6. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 7. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES VACCINE VIALS MARKET: MARKET DYNAMICS
FIGURE 9. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 10. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2026
FIGURE 12. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2026
FIGURE 19. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (%)
FIGURE 24. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2020 VS 2026 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2026
FIGURE 26. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, 2018-2026 (USD MILLION)
FIGURE 27. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 28. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 30. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (%)
FIGURE 31. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2020 VS 2026 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2026
FIGURE 33. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. CALIFORNIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. FLORIDA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ILLINOIS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. NEW YORK VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. OHIO VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. PENNSYLVANIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. TEXAS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES VACCINE VIALS MARKET: FPNV POSITIONING MATRIX
FIGURE 51. UNITED STATES VACCINE VIALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 52. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VACCINE VIALS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES VACCINE VIALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. CALIFORNIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. FLORIDA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. ILLINOIS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. NEW YORK VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. OHIO VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. PENNSYLVANIA VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. TEXAS VACCINE VIALS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES VACCINE VIALS MARKET: SCORES
TABLE 27. UNITED STATES VACCINE VIALS MARKET: BUSINESS STRATEGY
TABLE 28. UNITED STATES VACCINE VIALS MARKET: PRODUCT SATISFACTION
TABLE 29. UNITED STATES VACCINE VIALS MARKET: RANKING
TABLE 30. UNITED STATES VACCINE VIALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 31. UNITED STATES VACCINE VIALS MARKET: MERGER & ACQUISITION
TABLE 32. UNITED STATES VACCINE VIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 33. UNITED STATES VACCINE VIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 34. UNITED STATES VACCINE VIALS MARKET: INVESTMENT & FUNDING
TABLE 35. UNITED STATES VACCINE VIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 36. UNITED STATES VACCINE VIALS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll